Press release
Immune-Mediated Inflammatory Diseases Market Know the Scope and Trends
According to the latest research by InsightAce Analytic, the Immune-Mediated Inflammatory Diseases Market is predicted to grow with a CAGR of 7.10% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2889
Immune-mediated inflammatory diseases (IMIDs) represent a group of interrelated disorders characterized by a common inflammatory pathway, in which immune system dysregulation triggers persistent inflammation despite an often unclear underlying cause. These conditions arise from an overactive or abnormal immune response and are frequently associated with an increased risk of organ damage, leading to higher rates of morbidity and, in some cases, mortality.
revalence of autoimmune and immune-mediated disorders continues to rise steadily, driven by a combination of genetic susceptibility, lifestyle factors, and unhealthy dietary patterns. As the incidence of these conditions increases worldwide, demand for effective diagnostic and therapeutic solutions is expanding, thereby contributing to the growth of the global market for immune-mediated inflammatory diseases.
List of Prominent Players in the Immune-Mediated Inflammatory Diseases Market:
• Novartis AG
• Daiichi Sankyo Company, Limited
• Pfizer Inc.
• Abbvie Inc.
• Merck & Co Inc.
• Zydus Group
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceuticals Industries Ltd.
• Amgen Inc.
• Boehringer Ingelheim International GmbH.
• AstraZeneca
• Ampio Pharmaceuticals Inc.
• Eli Lilly
• Akorn Incorporated
Market Dynamics:
Drivers-
The market for immune-mediated inflammatory diseases is expected to expand due to the rising prevalence of conditions such as psoriasis, Crohn's disease, and rheumatoid arthritis. Market growth is further supported by the increasing adoption of advanced and targeted biologic therapies designed to improve treatment outcomes for these disorders. In addition, the expanding availability of treatments through hospitals, specialty clinics, retail pharmacies, and online pharmacy platforms is enhancing patient access, thereby contributing to overall market development.
Enquiry Before Buying:
@ https://www.insightaceanalytic.com/buy-report/2889
Challenges:
The global immune-mediated inflammatory diseases market may face growth constraints during the forecast period due to a shortage of skilled healthcare professionals capable of administering specialized treatments. Moreover, adverse effects associated with certain therapeutic approaches, including immunosuppressive drugs, may limit wider adoption. Side effects such as skin reactions and therapy-induced autoimmune responses can negatively impact patient compliance.
Regional Trends:
North America is expected to account for a significant share of the immune-mediated inflammatory diseases market in terms of revenue. This growth is driven by the increasing incidence of autoimmune disorders, strong demand for innovative treatment options, and a heightened focus on targeted biologic therapies. The region also benefits from a growing number of regulatory approvals for novel therapies and rising demand for immunosuppressive drugs. Additionally, the Asia Pacific region holds a substantial market share, supported by increasing disease awareness, a growing patient population, and ongoing technological advancements in the management and treatment of immune-mediated inflammatory diseases.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2889
Recent Developments:
• In July 2024, AbbVie announced that the European Commission has sanctioned SKYRIZI® (risankizumab) for the treatment of elderly individuals with moderately to severely active ulcerative colitis (UC) who have experienced an inadequate response to, lost response to, or exhibited intolerance to conventional or biologic therapies.
Segmentation of Immune-Mediated Inflammatory Diseases Market-
By Indication-
• Asthma,
• Chronic Obstructive Pulmonary Diseases (COPD)
• Inflammatory Bowel Disease (IBD)
• Systemic Lupus Erythematosus (SLE)
• Rheumatoid Arthritis (RA)
• Psoriasis
• Others
By Treatment Type-
• Traditional Drugs
• Biologic Therapies
• Novel Therapies
By Route of Administration-
• Oral
• Parenteral
• Others
By End-Users-
• Hospitals
• Specialty Clinics
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get More Information :
https://www.insightaceanalytic.com/report/immune-mediated-inflammatory-diseases-market/2889
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immune-Mediated Inflammatory Diseases Market Know the Scope and Trends here
News-ID: 4353394 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
RNA-Targeted Small Molecules Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " RNA-Targeted Small Molecules Market - (By Product & Service (mRNA translation regulation, Indirect RNA targeting-epitranscriptomics, RNA Splicing Modification, Direct RNA Targeting), By Application (Drug discovery, Oncology research, Disease identification), By End-User (Hospitals, Research laboratories, Contract research organizations, Pharmaceutical and biotechnology companies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by…
Reefer Container For Pharmaceutical Market Report on the Untapped Growth Opportu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Reefer Container for Pharmaceutical Market Size, Share & Trends Analysis Report By Container Size (20 Feet, 40 Feet, And High Cube), Mode Of Transportation (Roadways, Railways, And Seaways), And Technology (Conventional Reefer And Advanced Reefer), Region, Market Outlook And Industry Analysis 2031"
The Global Reefer Container For Pharmaceutical Market is estimated to reach over USD 4.9…
One Step RT-qPCR Kits Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " One Step RT-qPCR Kits Market - (By Reaction (25 Rxn one step RT-qPCR kits, 50 Rxn one step RT-qPCR kits, 100 Rxn one step RT-qPCR kits, 200 Rxn one step RT-qPCR kits, 400 Rxn one step RT-qPCR kits, 500 Rxn one step RT-qPCR kits, 1000 Rxn one step RT-qPCR kits, and above 1000 Rxn one-step…
Autosomal Dominant Hypocalcemia Type 1 Market Exclusive Report on the Latest Rev …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Autosomal Dominant Hypocalcemia Type 1 Market - (By Treatment (Calcium Analogs, Vitamin Analogs), By End-User (Hospitals, Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Autosomal Dominant Hypocalcemia Type 1 Market is predicted to grow with a CAGR of 2.96% during the forecast period of…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
